Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
epirubicinhydroklorid 200 mg/100 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
cidofovir 375 mg/5 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
epirubicinhydroklorid 10 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
kladribin 10 mg/10 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
abciximab 10 mg/5 ml injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
fluorouracil (som fluorouracilnatrium) 500 mg/20 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
paracetamol 500 mg/50 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
aciklovir (som aciklovirnatrium) 500 mg/20 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
aciklovir (som aciklovirnatrium) 1 g/40 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
aciklovir (som aciklovirnatrium) 250 mg/10 ml infusionvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
cytarabin 1 g/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
adenosin 30 mg/10 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
cytarabin 100 mg/ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
adenosin 6 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
cytarabin 2 g/20 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
cytarabin 500 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
epoetin alfa 40 000 enheter/ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
bevacizumab 400 mg/16 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
cytarabin 500 mg/25 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
bevacizumab 100 mg/4 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
amikacin (som amikacinsulfat) 100 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
amikacin (som amikacinsulfat) 500 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
dalteparinnatrium 100 000 enheter/4 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
eptifibatid 20 mg/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
eptifibatid 75 mg/100 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
esmololhydroklorid 100 mg/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
argatrobanmonohydrat 250 mg/2,5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
atosiban (som atosibanacetat) 37,5 mg/5 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
atosiban (som atosibanacetat) 6,75 mg/0,9 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
propofol 200 mg/20 ml, injektionsvätska, emulsion, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
metotrexat (som metotrexatnatrium) 5 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
lidokainhydroklorid 400 mg/20 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
panitumumab 100 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
vinkristinsulfat 1 mg/ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
vinkristinsulfat 2 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
oktreotid (som oktreotidacetat) 1 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
doxorubicinhydroklorid 20 mg/10 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
humant insulin (som humant lösligt insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
vinkristinsulfat 5 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
propofol 1 g/50 ml, injektionsvätska, emulsion, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
doxorubicinhydroklorid 50 mg/25 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
metotrexat (som metotrexatnatrium) 500 mg/20 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
vinorelbin (som vinorelbintartrat) 10 mg/ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
vinorelbin (som vinorelbintartrat) 50 mg/5 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
idarubicinhydroklorid 10 mg/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
fosfenytoinnatrium 750 mg/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
zikonotid (som zikonotidacetat) 100 mikrogram/ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
idarubicinhydroklorid 5 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
triamcinolonacetonid 50 mg/5 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
zikonotid (som zikonotidacetat) 500 mikrogram/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
iduronat-2-sulfatas 6 mg/3 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
mekasermin 40 mg/4 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
metotrexat (som metotrexatnatrium) 1 g/40 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
aspartinsulin 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
medroxiprogesteronacetat 500 mg/2,5 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
pegaspargas 3 750 enheter/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
humant insulin (som glargininsulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
rituximab 100 mg/10 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
gentamicin (som gentamicinsulfat) 80 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
rokuroniumbromid 100 mg/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
rokuroniumbromid 50 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
tinzaparinnatrium 40 000 enheter/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
paklitaxel 150 mg/25 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
paklitaxel 300 mg/50 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
palonosetron (som palonosetronhydroklorid) 250 mikrogram/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
metotrexat (som metotrexatnatrium) 1 g/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
galsulfas 5 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
dinatriumpamidronat 15 mg/5 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
lisproinsulin 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
rituximab 500 mg/50 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
laxkalcitonin 400 enheter/2ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
metotrexat (som metotrexatnatrium) 5 g/50 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
metotrexat (som metotrexatnatrium) 50 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
bovint insulin (som olösligt bovint insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
natriumklorid 900 mg/100 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
metotrexat (som metotrexatnatrium) 200 mg/8 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
humant insulin (som humant lösligt insulin) 500 enheter/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
natriumklorid 180 mg/20 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
jod (som jotrolan) 2,4 g/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
natriumklorid 450 mg/50 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
metylprednisolonacetat 120 mg/3 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
bovint insulin (som bovint lösligt protaminzinkinsulin) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
natriumklorid 45 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
insulin från gris (som porcint lösligt insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
propofol 500 mg/50 ml, injektionsvätska, emulsion, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
metotrexat (som metotrexatnatrium) 5 g/200ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
metylnaltrexonbromid 12 mg/0,6 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
gentamicin (som gentamicinsulfat) 20 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
humant insulin (som kristallinsk human zinkinsulinsuspension) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
metylprednisolonacetat 40 mg/ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
humant insulin (som blandad human zinkinsulinsuspension) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
fenol 1,25 g/25 ml, olja för injektion, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
irinotekanhydrokloridtrihydrat 40 mg/2 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
irinotekanhydrokloridtrihydrat 100 mg/5 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
nitroglycerin 50 mg/50 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
järn (som järnsackaros) 50 mg/2,5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
ketamin (som ketaminhydroklorid) 1 g/10 ml, injektionsvätska, lösning, ampull |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|